Jie-Huei Wang

Prof. Dr. Jie-Huei Wang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2024 in Nutrition & Diabetes
Verified
Journal Article
Open access
PDF file
MCMei-Chun Chien
Mei-Chun Chien
CHChueh-Yi Huang
Chueh-Yi Huang
JWJie-Huei Wang
Jie-Huei Wang
CSChia-Lung Shih
Chia-Lung Shih
PWPensee Wu
Pensee Wu
Background: Vitamin D deficiency has been linked with several adverse maternal and fetal outcomes. Objective: To summarize systematic reviews and meta-analyses evaluating the effects of vitamin D deficiency and of vitamin D supplementation in pregnancy on maternal and offspring health-related outcomes. Methods: Prior to conducting this umbrella review, we registered the protocol in PROSPERO (CRD42022368003). We conducted searches in PubMed, Embase, and Cochrane Library for systematic reviews and meta-analyses on vitamin D in pregnancy, from database inception to October 2, 2023. All outcomes related to vitamin D in pregnancy obtained from the systematic reviews and meta-analyses were extracted. Data Extraction: Two reviewers independently chose studies and collected information on health outcomes. The quality of the included articles’ methodology was assessed using AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews–2). Results: We identified 16 eligible systematic reviews and meta-analyses, which included 250,569 women. Our results demonstrated that vitamin D deficiency in pregnancy is associated with increased risk of preterm birth, small-for gestational age/low birth weight infants, recurrent miscarriage, bacterial vaginosis and gestational diabetes mellitus. Vitamin D supplementation in pregnancy increases birth weight, and reduces the risk of maternal pre-eclampsia, miscarriage, and vitamin D deficiency, fetal or neonatal mortality, as well as attention-deficit hyperactivity disorder, and autism spectrum disorder in childhood. In women with gestational diabetes mellitus, vitamin D supplementation in pregnancy can reduce the risk of maternal hyperbilirubinemia, polyhydramnios, macrosomia, fetal distress, and neonatal hospitalization. Conclusion: Due to the association with adverse maternal and offspring health outcomes, we recommend the vitamin D status in pregnancy should be monitored, particularly in women at high risk of vitamin D deficiency. It is suggested that pregnant women take a dose of >400 IU/day of vitamin D supplementation during pregnancy to prevent certain adverse outcomes.

29 January 2021 in Bioinformatics
Verified
Journal Article
Open access
PDF file
JWJie-Huei Wang
Jie-Huei Wang
YCYi-Hau Chen
Yi-Hau Chen
In high-dimensional genetic/genomic data, the identification of genes related to clinical survival trait is a challenging and important issue. In particular, right-censored survival outcomes and contaminated biomarker data make the relevant feature screening difficult. Several independence screening methods have been developed, but they fail to account for gene–gene dependency information, and may be sensitive to outlying feature data. We improve the inverse probability-of-censoring weighted (IPCW) Kendall’s tau statistic by using Google’s PageRank Markov matrix to incorporate feature dependency network information. Also, to tackle outlying feature data, the nonparanormal approach transforming the feature data to multivariate normal variates are utilized in the graphical lasso procedure to estimate the network structure in feature data. Simulation studies under various scenarios show that the proposed network-adjusted weighted Kendall’s tau approach leads to more accurate feature selection and survival prediction than the methods without accounting for feature dependency network information and outlying feature data. The applications on the clinical survival outcome data of diffuse large B-cell lymphoma and of The Cancer Genome Atlas lung adenocarcinoma patients demonstrate clearly the advantages of the new proposal over the alternative methods. Supplementary data are available at Bioinformatics online.

15 July 2024 in Mathematics
Verified
Journal Article
Open access
PDF file
JWJie-Huei Wang
Jie-Huei Wang
CLCHENG YU LIU
CHENG YU LIU
YMYou-Ruei Min
You-Ruei Min
子吳子漢 吳
子漢 吳
PHPo-Lin Hou
Po-Lin Hou
The complexity of cancer development involves intricate interactions among multiple biomarkers, such as gene-environment interactions. Utilizing microarray gene expression profile data for cancer classification is anticipated to be effective, thus drawing considerable interest in the fields of bioinformatics and computational biology. Due to the characteristics of genomic data, problems of high-dimensional interactions and noise interference do exist during the analysis process. When building cancer diagnosis models, we often face the dilemma of model adaptation errors due to an imbalance of data types. To mitigate the issues, we apply the SMOTE-Tomek procedure to rectify the imbalance problem. Following this, we utilize the overlapping group screening method alongside a binary logistic regression model to integrate gene pathway information, facilitating the identification of significant biomarkers associated with clinically imbalanced cancer or normal outcomes. Simulation studies across different imbalanced rates and gene structures validate our proposed method’s effectiveness, surpassing common machine learning techniques in terms of classification prediction accuracy. We also demonstrate that prediction performance improves with SMOTE-Tomek treatment compared to no imbalance treatment and SMOTE treatment across various imbalance rates. In the real-world application, we integrate clinical and gene expression data with prior pathway information. We employ SMOTE-Tomek and our proposed methods to identify critical biomarkers and gene-environment interactions linked to the imbalanced binary outcomes (cancer or normal) in patients from the Cancer Genome Atlas datasets of lung adenocarcinoma and breast invasive carcinoma. Our proposed method consistently achieves satisfactory classification accuracy. Additionally, we have identified biomarkers indicative of gene-environment interactions relevant to cancer and have provided corresponding estimates of odds ratios. Moreover, in high-dimensional imbalanced data, for achieving good prediction results, we recommend considering the order of balancing processing and feature screening.

18 July 2022 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
JWJie-Huei Wang
Jie-Huei Wang
CYChun-Ting Yang
Chun-Ting Yang
Background: In biomedical and epidemiological studies, gene-environment (G-E) interactions play an important role in the etiology and progression of many complex diseases. In ultra-high-dimensional survival genomic data, two common approaches (marginal and joint models) are proposed to determine important interaction biomarkers. Most existing methods for detecting G-E interactions (marginal Cox model and marginal accelerated failure time model) are limited by a lack of robustness to contamination/outliers in response outcome and prediction biomarkers. In particular, right-censored survival outcomes and ultra-high-dimensional feature space make relevant feature screening even more challenging. Methods: In this paper, we utilize the non-parametric Kendall’s partial correlation method to obtain pure correlation to determine the importance of G-E interactions concerning clinical survival data under a marginal modeling framework. Results: A series of simulated scenarios are conducted to compare the performance of our proposed method (Kendall’s partial correlation) with some commonly used methods (marginal Cox’s model, marginal accelerated failure time model, and censoring quantile partial correlation approach). In real data applications, we utilize Kendall’s partial correlation method to identify G-E interactions related to the clinical survival results of patients with esophageal, pancreatic, and lung carcinomas using The Cancer Genome Atlas clinical survival genetic data, and further establish survival prediction models. Conclusions: Overall, both simulation with medium censoring level and real data studies show that our method performs well and outperforms existing methods in the selection, estimation, and prediction accuracy of main and interacting biomarkers. These applications reveal the advantages of the non-parametric Kendall’s partial correlation approach over alternative semi-parametric marginal modeling methods. We also identified the cancer-related G-E interactions biomarkers and reported the corresponding coefficients with p-values.

23 May 2021 in Communications in Statistics - Theory and Methods
Verified
Journal Article
Closed access
SWShuo-Jye Wu
Shuo-Jye Wu
SHSyuan-Rong Huang
Syuan-Rong Huang
JWJie-Huei Wang
Jie-Huei Wang
An important goal for the producers is to stimulate the purchase intention of consumers so that the profit can be increased. An attractive warranty policy can not only represent the quality of product but also enhance the purchase desire of consumers. A long warranty length usually stands for high quality. However, it is not suitable for the producers to provide an unlimited warranty length. The main purpose of this paper is to establish an approach to determine the optimal warranty length based on one-shot device sample. The one-shot device data are collected under a multiple-level constant-stress accelerated life test. The lifetime distribution at each stress level is assumed to be Rayleigh. A utility function is provided to measure the monetary profit based on a free-replacement warranty policy. The optimization problem is studied under the Bayesian framework. A numerical example is studied for illustrating purpose. Finally, the sensitivity analysis is performed to see the influence of some parameters on the optimal warranty length.

30 May 2022 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
JWJie-Huei Wang
Jie-Huei Wang
KWKang-Hsin Wang
Kang-Hsin Wang
Yi-Hau ChenYi-Hau Chen
Yi-Hau Chen
Background: In the context of biomedical and epidemiological research, gene-environment (G-E) interaction is of great significance to the etiology and progression of many complex diseases. In high-dimensional genetic data, two general models, marginal and joint models, are proposed to identify important interaction factors. Most existing approaches for identifying G-E interactions are limited owing to the lack of robustness to outliers/contamination in response and predictor data. In particular, right-censored survival outcomes make the associated feature screening even challenging. In this article, we utilize the overlapping group screening (OGS) approach to select important G-E interactions related to clinical survival outcomes by incorporating the gene pathway information under a joint modeling framework. Results: Simulation studies under various scenarios are carried out to compare the performances of our proposed method with some commonly used methods. In the real data applications, we use our proposed method to identify G-E interactions related to the clinical survival outcomes of patients with head and neck squamous cell carcinoma, and esophageal carcinoma in The Cancer Genome Atlas clinical survival genetic data, and further establish corresponding survival prediction models. Both simulation and real data studies show that our method performs well and outperforms existing methods in the G-E interaction selection, effect estimation, and survival prediction accuracy. Conclusions: The OGS approach is useful for selecting important environmental factors, genes and G-E interactions in the ultra-high dimensional feature space. The prediction ability of OGS with the Lasso penalty is better than existing methods. The same idea of the OGS approach can apply to other outcome models, such as the proportional odds survival time model, the logistic regression model for binary outcomes, and the multinomial logistic regression model for multi-class outcomes.